In his state of the union address last night, President Trump said reducing prescription drug prices is “one of my greatest priorities.” Among other health care-related comments, Trump said his administration “is committed to fighting the drug epidemic and helping get treatment for those in need.” He also said it is “time to rebuild our crumbling infrastructure,” and called on Congress to produce a bill that generates at least $1.5 trillion for new infrastructure investment. Commenting on the speech, AHA President and CEO Rick Pollack said, “Along with the Administration’s commitment to reversing the tide of drug addiction and addressing the rising costs of prescription drugs, we support the need to address America’s infrastructure. Hospitals and health care should be part of any effort to fix and improve our nation’s infrastructure. Just as America’s infrastructure must be rebuilt, our health care infrastructure must also be revitalized. More specifically, infrastructure investments are needed to help hospitals meet the needs of their communities, strengthen the capacity for emergency preparedness and response, expand the digital infrastructure for health care, and ensure adequate financing mechanisms for hospitals and health systems. We appreciate the Administration’s support for revitalizing advanced refinancing for tax-exempt bonds.”

Headline
The administration Apri 23 reached a most-favored-nation drug pricing agreement with Regeneron, the maker of the popular cholesterol medicine Praluent. This is…
Headline
The Centers for Medicare & Medicaid Services announced in a memo April 21that it is delaying implementation of the Medicare Part D portion of the Better…
Headline
President Trump April 18 signed an executive order to accelerate research into psychedelic drugs for the treatment of serious mental illnesses, calling…
Headline
The U.S. Court of Appeals for the 5th Circuit April 9 affirmed rulings by a Mississippi district court that rejected requests by Novartis and PhRMA to enjoin…
Headline
The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ingredients. The order imposes a…
Headline
The Centers for Medicare & Medicaid Services April 2 released a final rule on policy and technical changes to Medicare Advantage, the Medicare Prescription…